US-based mutual fund manager Fidelity Investments’s biosciences venture unit is to launch a UK operation next month.
Fidelity Biosciences, which has Fidelity as its limited partner, is one of the largest venture units in life sciences with an 18-strong team and Simon Clark, managing partner of the separate Fidelity Growth Partners, said last week the biotech unit’s European expansion would begin in the UK.
The move follows medical device company Johnson & Johnson’s (J&J) corporate venturing unit setting up an…
